Tango Therapeutics, Inc.
TNGX
Rank in Stocks
#4542
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and... Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
Share Price
$27.18
Last synced: 2026-07-31
Market Cap
$3.38B
Change (1 day)
-1.41%
Change (1 year)
197.05%
Country
US
Trade Tango Therapeutics, Inc. (TNGX)
Category
Healthcare
Number of shares outstanding for Tango Therapeutics, Inc. (TNGX)
Number of shares outstanding as of June 2026: 149.88M
According to Tango Therapeutics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 149.88M. At the end of December 2023 the company had 94.57M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Tango Therapeutics, Inc. (TNGX) from 2019 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 149.88M | 37.22% |
| 2024 | 109.23M | 15.50% |
| 2023 | 94.57M | 7.69% |
| 2022 | 87.82M | 41.40% |
| 2021 | 62.11M | -29.00% |
| 2020 | 87.47M | 0.00% |
| 2019 | 87.47M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | 69.41% |
US
|
|
| 396.00M | 164.22% |
US
|
|
| 478.91M | 219.54% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -58.51% |
NL
|
